FLGC Valuation

Flora Growth Corp

Add to Watchlist

Advanced Chart

7.100

+0.225(3.273%)1D

FLGC Relative Valuation

FLGC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, FLGC is overvalued; if below, it's undervalued.

Historical Valuation

Flora Growth Corp (FLGC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -16.39. The fair price of Flora Growth Corp (FLGC) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：7.10

Fair

-3.94

Trailing

Forward

1.08

EV/EBITDA

Flora Growth Corp. (FLGC) has a current EV/EBITDA of 1.08. The 5-year average EV/EBITDA is -22.06. The thresholds are as follows: Strongly Undervalued below -215.24, Undervalued between -215.24 and -118.65, Fairly Valued between 74.53 and -118.65, Overvalued between 74.53 and 171.12, and Strongly Overvalued above 171.12. The current Forward EV/EBITDA of 1.08 falls within the Historic Trend Line -Fairly Valued range.

0.97

EV/EBIT

Flora Growth Corp. (FLGC) has a current EV/EBIT of 0.97. The 5-year average EV/EBIT is -8.23. The thresholds are as follows: Strongly Undervalued below -56.35, Undervalued between -56.35 and -32.29, Fairly Valued between 15.83 and -32.29, Overvalued between 15.83 and 39.89, and Strongly Overvalued above 39.89. The current Forward EV/EBIT of 0.97 falls within the Historic Trend Line -Fairly Valued range.

0.10

Flora Growth Corp. (FLGC) has a current PS of 0.10. The 5-year average PS is 1.65. The thresholds are as follows: Strongly Undervalued below -5.00, Undervalued between -5.00 and -1.67, Fairly Valued between 4.97 and -1.67, Overvalued between 4.97 and 8.29, and Strongly Overvalued above 8.29. The current Forward PS of 0.10 falls within the Historic Trend Line -Fairly Valued range.

-4.41

P/OCF

Flora Growth Corp. (FLGC) has a current P/OCF of -4.41. The 5-year average P/OCF is -1.87. The thresholds are as follows: Strongly Undervalued below -46.56, Undervalued between -46.56 and -24.22, Fairly Valued between 20.47 and -24.22, Overvalued between 20.47 and 42.82, and Strongly Overvalued above 42.82. The current Forward P/OCF of -4.41 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Flora Growth Corp. (FLGC) has a current P/FCF of 0.00. The 5-year average P/FCF is 41.74. The thresholds are as follows: Strongly Undervalued below -316.35, Undervalued between -316.35 and -137.31, Fairly Valued between 220.79 and -137.31, Overvalued between 220.79 and 399.83, and Strongly Overvalued above 399.83. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Flora Growth Corp (FLGC) has a current Price-to-Book (P/B) ratio of 0.08. Compared to its 3-year average P/B ratio of 1.96 , the current P/B ratio is approximately -96.03% higher. Relative to its 5-year average P/B ratio of 2.51, the current P/B ratio is about -96.90% higher. Flora Growth Corp (FLGC) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -56.80%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -46.67% , the current FCF yield is about -100.00% lower.

0.08

P/B

Median3y

1.96

Median5y

2.51

-136.62

FCF Yield

Median3y

-56.80

Median5y

-46.67

Competitors Valuation Multiple

The average P/S ratio for FLGC's competitors is 0.00, providing a benchmark for relative valuation. Flora Growth Corp Corp (FLGC) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 34.68%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

PharmaCyte Biotech Inc

Loss

4.42M

ASBP.O

Aspire Biopharma Holdings Inc

Loss

10.47M

QLGN.O

Aixcrypto Holdings Inc

Loss

1.12M

ENVB.O

Enveric Biosciences Inc

Loss

3.56M

Performance Decomposition

Market capitalization of FLGC decreased by 89.54% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 7.24M to 9.75M.

The secondary factor is the Margin Expansion, contributed 15.77%to the performance.

Overall, the performance of FLGC in the past 1 year is driven by Revenue Growth. Which is more sustainable.

34.68%

7.24M → 9.75M

Revenue Growth

15.77%

-32.14 → -37.21

Margin Expansion

-139.99%

0.61 → -0.24

P/E Change

-89.54%